Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage/Experiment 1/Signature 1
From BugSigDB
< Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage | Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage/Experiment 1
Reviewed Marked as Reviewed by Fatima on 2022/09/7
Source: Table 2, Figure 2B, text
Description: Comparison of the distribution of gut microbiota between the metronomic group and the routine group at different levels. (B) Distribution of the gut microbiota composition in the metronomic group and the routine group at the genus level.
Abundance in Group 1: increased abundance in responders (patients treated with metronomic dose of capecitabine)
| NCBI | Quality Control | Links |
|---|---|---|
| Megamonas | ||
| Veillonellaceae | ||
| Veillonella | ||
| Veillonella sp. | ||
| Veillonellales | ||
| Megamonas sp. | ||
| unclassified Megamonas | ||
| unclassified Veillonella | ||
| unclassified Veillonellaceae |
